| Literature DB >> 12213072 |
Peter Nussbaumer1, Philipp Lehr, Andreas Billich.
Abstract
Steroid sulfatase (STS) has emerged as a highly attractive target for the therapy of a number of disorders. Starting with the known inhibitor estrone sulfamate (1) as lead compound and with the finding that steroid sulfamates containing a nonaromatic A-ring are inactive, chromen-4-one sulfamates were designed, prepared, and tested for their ability to block human STS. This new class of nonsteroidal inhibitors shows high potency when the sulfamate group and the side chain are situated in diagonally opposite positions (i.e., 2,6- and 3,7-substitution pattern). The highest activity is achieved with fully branched, bulky aliphatic side chains and with thiochromen-4-one as the core element. 2-(1-Adamantyl)-4H-thiochromen-4-on-6-O-sulfamate (6c) is the most potent STS inhibitor discovered so far, and it is about 170-fold superior to 1. As with 1, all chromenone sulfamates are irreversible inhibitors of STS with a biphasic time course of inactivation.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12213072 DOI: 10.1021/jm020878w
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446